Table 2.
Compound | Conc. Unit | IC50 a | ||
---|---|---|---|---|
Human TK-1 | Human TK-2 | HSV-1 TK | ||
2a | µg/mL | >200 | >200 | 150 ± 15 |
2b | µg/mL | >200 | 93 ± 7 | 1.6 ± 0.1 |
2c | µg/mL | >200 | >200 | >200 |
2d | µg/mL | >200 | >200 | 52 ± 28 |
2e | µg/mL | >100 | >100 | >100 |
a 50% inhibitory concentration, or compound concentration required to inhibit TK-catalyzed conversion of [3H]dThd to its 5′-monophosphate derivative.